Extremely low doses of lepirudin in a patient with heparin-induced thrombocytopenia, high bleeding risk and renal insufficiency.
Tardy-Poncet
Brigitte
B
Charier
David
D
Diconne
Eric
E
Zeni
Fabrice
F
Garraud
Olivier
O
Tardy
Bernard
B
Campos
Lydia
L
D000925:Anticoagulants / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000097:blood / Q000188:drug therapy; D002543:Cerebral Hemorrhage / Q000139:chemically induced / Q000188:drug therapy; D004334:Drug Administration Schedule; D006207:Half-Life; D006493:Heparin / Q000009:adverse effects*; D006629:Hirudins / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D051437:Renal Insufficiency / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000188:drug therapy*; D016896:Treatment Outcome
D000925:Anticoagulants; D006629:Hirudins; D011994:Recombinant Proteins; D006493:Heparin; C083544:lepirudin